CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 2/3, Multi-Center, Open-Label, Randomized Study of Weekly Nab®-Paclitaxel in Combination With Gemcitabine or Carboplatin, Compared to Gemcitabine/Carboplatin, as First Line Treatment in Subjects With ER, PgR, and HER2 Negative (Triple Negative) Metastatic Breast Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01881230
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:00.259723+00:00
- Published At
- 2018-03-08T00:00:00+00:00
- Record Updated At
- 2019-02-21
- Results Posted At
- 2018-03-08
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Breast Tumor", "Breast Cancer", "Cancer of the Breast", "Estrogen Receptor- Negative Breast Cancer", "HER2- Negative Breast Cancer", "Progesterone Receptor- Negative Breast Cancer", "Recurrent Breast Cancer", "Stage IV Breast Cancer", "Triple-negative Breast Cancer", "Triple-negative Metastatic Breast Cancer", "Metastatic Breast Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-02-21"- protocolSection.identificationModule.nctId
"NCT01881230"- protocolSection.identificationModule.officialTitle
"A Phase 2/3, Multi-Center, Open-Label, Randomized Study of Weekly Nab\u00ae-Paclitaxel in Combination With Gemcitabine or Carboplatin, Compared to Gemcitabine/Carboplatin, as First Line Treatment in Subjects With ER, PgR, and HER2 Negative (Triple Negative) Metastatic Breast Cancer"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2", "PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-03-08"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.